{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:27:57Z","timestamp":1761395277204},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.saa.2018.07.017","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T19:38:36Z","timestamp":1530992316000},"page":"290-297","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and\/or ledipasvir utilizing direct and H-point standard addition strategies"],"prefix":"10.1016","volume":"210","author":[{"given":"Sabrein H.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousry M.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyaa I.","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2018.07.017_bb0005","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1021\/jm401507s","article-title":"Discovery and development of simeprevir (TMC435), a HCV NS3\/4A protease inhibitor","volume":"57","author":"Rosenquist","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.saa.2018.07.017_bb0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.saa.2018.07.017_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.saa.2018.07.017_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchromb.2014.02.028","article-title":"Determination of simeprevir: a novel, hepatitis C protease inhibitor in human plasma by high-performance liquid chromatography-tandem mass spectrometry","volume":"958","author":"Vanwelkenhuysen","year":"2014","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2018.07.017_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.saa.2017.08.066","article-title":"Different spectrophotometric methods applied for the analysis of simeprevir in the presence of its oxidative degradation product: a comparative study","volume":"190","author":"Attia","year":"2018","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2018.07.017_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpba.2016.01.019","article-title":"Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma","volume":"121","author":"Nannetti","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2018.07.017_bb0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jpba.2016.04.031","article-title":"A UHPLC-MS\/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir\/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma","volume":"125","author":"Ariaudo","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2018.07.017_bb0040","first-page":"4508","article-title":"A new validated RP-HPLC method for the simultaneous determination of simeprevir and sofosbuvir in pharmaceutical dosage form","volume":"6","author":"Raj Kumar","year":"2016","journal-title":"Indo Am. Pharm. Res."},{"key":"10.1016\/j.saa.2018.07.017_bb0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/22297928.2017.1287004","article-title":"Stability-indicating HPLC-DAD method for the determination of Simeprevir","volume":"7","author":"Attia","year":"2017","journal-title":"Anal. Chem. Lett."},{"key":"10.1016\/j.saa.2018.07.017_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.clinthera.2014.12.012","article-title":"Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection","volume":"37","author":"Childs-Kean","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.saa.2018.07.017_bb0055","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jhep.2016.02.022","article-title":"HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir","volume":"64","author":"Dahari","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.saa.2018.07.017_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.talanta.2014.01.012","article-title":"Spectra resolution for simultaneous spectrophotometric determination of lamivudine and zidovudine components in pharmaceutical formulation of human immunodeficiency virus drug based on using continuous wavelet transform and derivative transform techniques","volume":"122","author":"Sohrabi","year":"2014","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2018.07.017_bb0065","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jfda.2017.01.009","article-title":"Convenient UV-spectrophotometric determination of citrates in aqueous solutions with applications in the pharmaceutical analysis of oral electrolyte formulations","volume":"25","author":"Krukowski","year":"2017","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.saa.2018.07.017_bb0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1039\/AN9901500111","article-title":"Letters","volume":"115","author":"Bosch-Reig","year":"1990","journal-title":"Analyst"},{"key":"10.1016\/j.saa.2018.07.017_bb0075","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0039-9140(02)00133-9","article-title":"Simultaneous determination of Fe(II) and Fe(III) by kinetic spectrophotometric H-point standard addition method","volume":"57","author":"Zolgharnein","year":"2002","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2018.07.017_bb0080","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.talanta.2005.08.038","article-title":"H-point standard addition method for simultaneous determination of Fe(II), Co(II) and Cu(II) in micellar media with simultaneous addition of three analytes","volume":"68","author":"Hasani","year":"2006","journal-title":"Talanta"},{"issue":"16","key":"10.1016\/j.saa.2018.07.017_bb0085","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3923\/jas.2010.1802.1805","article-title":"Application of H-point standard addition method for simultaneous determination of levonorgestrel and ethinylestradiol in oral contraceptives LD","volume":"10","author":"Sohrabi","year":"2010","journal-title":"J. Appl. Sci."},{"key":"10.1016\/j.saa.2018.07.017_bb0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/05704928.2011.570836","article-title":"H-point standard addition method (HPSAM) in simultaneous spectrophotometric determination of binary mixtures: an overview","volume":"46","author":"Al-Sabha","year":"2011","journal-title":"Appl. Spectrosc. Rev."},{"key":"10.1016\/j.saa.2018.07.017_bb0095","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1039\/AN9881301011","article-title":"H-point standard additions method. Part 1. Fundamentals and application to analytical spectroscopy","volume":"113","author":"Bosch-Reig","year":"1988","journal-title":"Analyst"},{"key":"10.1016\/j.saa.2018.07.017_bb0100","series-title":"Statistics for Analytical Chemistry","author":"Miller","year":"1993"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138614251830670X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138614251830670X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T20:27:38Z","timestamp":1545078458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138614251830670X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":20,"alternative-id":["S138614251830670X"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2018.07.017","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and\/or ledipasvir utilizing direct and H-point standard addition strategies","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2018.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}